#29: Racing To Cure COVID-19 with Dr. Jacob Glanville

JAYSON WALLER UNLEASHED

Jayson Waller

Business, Society & Culture, Entrepreneurship

4.4 • 649 Ratings

🗓️ 9 July 2020

⏱️ 62 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

It was wild timing for Dr. Jacob Glanville to be featured in the Netflix docuseries “Pandemic” precisely as the coronavirus spread in China in January. Even more interesting is that Glanville thinks he and his biotech company can win the race in bringing COVID-19 to its knees. True Underdog Jayson Waller and co-host John LeBlanc discover why Glanville is pursuing antibody treatments instead of a vaccine, and learn what Glanville’s forecast is for the cure. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	True underdog.
0:07.0	True underdog.
0:11.0	We have got an episode today that is going to be epic. We have Dr.
0:15.6	Jacob Glenville as our guest and our co-host, John LeBlanc. How are you doing Dr.
0:20.8	Jacob Glenville?
0:21.8	I'm doing great, Jason. Thanks for having me on. And John, how are you doing? I'm doing great, Jason.
0:22.8	Thanks for having me on.
0:23.9	And John, how are you doing?
0:25.4	Doing fantastic, excited to be here.
0:27.5	So John's in Michigan, he's really excited about this show
0:30.3	for all the listeners and viewers out there.
0:32.4	You guys are definitely in for a treat
0:33.9	but uh... dr glenville let's introduce yourself tell us who you are what you've
0:38.4	been working on and where you're at right now sure so yeah i'm jay clville. I'm the founder, CEO, and president of
0:45.6	Distributed Bio. Also, the spin-out we're creating called Centevacs. We have
0:52.0	been working since 2012 when I launched a company with two friends to develop
0:57.2	new antibody-based therapeutics. These are broad spectrum vaccines and engineered antibodies that do a better job than our bodies would do it
1:05.6	fighting pathogens, which conveniently means this year we are applying our technologies to the novel
1:11.2	coronavirus. So we're spinning out cinevax which is
1:13.6	holding that new therapeutic. We just had multiple national laboratories confirm that that
1:18.4	antibody is super potent at neutralizing viruses, but then also the really exciting thing is that it protects hamsters from getting
1:24.8	coronavirus. So if a hamster gets our anybody, it's chilling. And so right now we're now moving that forward.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Jayson Waller, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Jayson Waller and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.